Joint Media Release
16 September 2015
Based on the results from two large trials, the Australasian Society for HIV Medicine (ASHM) Sub-Committee for Guidance on HIV Management in Australia strongly recommends that all people with HIV, regardless of their viral load or CD4 count, consider starting HIV treatment.
The two international trials – START and TEMPRANO – have clearly shown that the benefits of starting antiretroviral therapy (ART) outweighs potential treatment side effects, even when someone is well with a high CD4 cell count. These studies add to previous studies showing that the risk of passing HIV onto another person is also dramatically reduced with the use of antiretroviral therapy.
"This recommendation provides Australians with HIV, their doctors and other health care workers with clear guidance that antiretroviral therapy is beneficial, irrespective of CD4 count, and should be started soon after HIV diagnosis" said Dr Julian Elliott, an HIV specialist from The Alfred Hospital and chair of the ASHM Sub-Committee.
Read full Joint Media Release.pdf